194 related articles for article (PubMed ID: 27906182)
21. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
22. The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner.
Nye MD; Almada LL; Fernandez-Barrena MG; Marks DL; Elsawa SF; Vrabel A; Tolosa EJ; Ellenrieder V; Fernandez-Zapico ME
J Biol Chem; 2014 May; 289(22):15495-506. PubMed ID: 24739390
[TBL] [Abstract][Full Text] [Related]
23. HOXB7 promotes malignant progression by activating the TGFβ signaling pathway.
Liu S; Jin K; Hui Y; Fu J; Jie C; Feng S; Reisman D; Wang Q; Fan D; Sukumar S; Chen H
Cancer Res; 2015 Feb; 75(4):709-19. PubMed ID: 25542862
[TBL] [Abstract][Full Text] [Related]
24. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
Chen J; Mitra A; Li S; Song S; Nguyen BN; Chen JS; Shin JH; Gough NR; Lin P; Obias V; He AR; Yao Z; Malta TM; Noushmehr H; Latham PS; Su X; Rashid A; Mishra B; Wu RC; Mishra L
Cancer Res; 2020 May; 80(9):1819-1832. PubMed ID: 32127355
[TBL] [Abstract][Full Text] [Related]
25. SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.
de Kroon LM; Narcisi R; van den Akker GG; Vitters EL; Blaney Davidson EN; van Osch GJ; van der Kraan PM
Sci Rep; 2017 Feb; 7():43164. PubMed ID: 28240243
[TBL] [Abstract][Full Text] [Related]
26. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
28. Interplay between transforming growth factor-β and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis.
Niu B; Liu J; Lv B; Lin J; Li X; Wu C; Jiang X; Zeng Z; Zhang XK; Zhou H
Nat Commun; 2021 May; 12(1):2809. PubMed ID: 33990575
[TBL] [Abstract][Full Text] [Related]
29. Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.
Oerlecke I; Bauer E; Dittmer A; Leyh B; Dittmer J
PLoS One; 2013; 8(1):e54261. PubMed ID: 23349840
[TBL] [Abstract][Full Text] [Related]
30. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
31. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
32. Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways.
Chen J; Huang X; Li N; Liu B; Ma Z; Ling J; Yang W; Li T
Mol Med Rep; 2020 Dec; 22(6):5113-5124. PubMed ID: 33174044
[TBL] [Abstract][Full Text] [Related]
33. Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site.
Huang CC; Huang MS; Chung HJ; Chiu SY; Yadav P; Lin Y; Liu F; Matsuura I
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3664-3671. PubMed ID: 30251686
[TBL] [Abstract][Full Text] [Related]
34. Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3.
Naz S; Bashir M; Ranganathan P; Bodapati P; Santosh V; Kondaiah P
Carcinogenesis; 2014 Jan; 35(1):14-23. PubMed ID: 23996929
[TBL] [Abstract][Full Text] [Related]
35. Angiopoietin-2, an angiogenic regulator, promotes initial growth and survival of breast cancer metastases to the lung through the integrin-linked kinase (ILK)-AKT-B cell lymphoma 2 (Bcl-2) pathway.
Imanishi Y; Hu B; Xiao G; Yao X; Cheng SY
J Biol Chem; 2011 Aug; 286(33):29249-29260. PubMed ID: 21680733
[TBL] [Abstract][Full Text] [Related]
36. JUNB governs a feed-forward network of TGFβ signaling that aggravates breast cancer invasion.
Sundqvist A; Morikawa M; Ren J; Vasilaki E; Kawasaki N; Kobayashi M; Koinuma D; Aburatani H; Miyazono K; Heldin CH; van Dam H; Ten Dijke P
Nucleic Acids Res; 2018 Feb; 46(3):1180-1195. PubMed ID: 29186616
[TBL] [Abstract][Full Text] [Related]
37. Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis.
Wu Y; Yu X; Yi X; Wu K; Dwabe S; Atefi M; Elshimali Y; Kemp KT; Bhat K; Haro J; Sarkissyan M; Vadgama JV
Cancer Res; 2017 Mar; 77(6):1383-1394. PubMed ID: 28115363
[TBL] [Abstract][Full Text] [Related]
38. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
Jin Q; Gao G; Mulder KM
J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of epithelial‑mesenchymal transition inhibited by miR‑203 in non‑small cell lung cancer.
Huang W; Wu Y; Cheng D; He Z
Oncol Rep; 2020 Feb; 43(2):437-446. PubMed ID: 31894278
[TBL] [Abstract][Full Text] [Related]
40. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells.
Dzwonek J; Preobrazhenska O; Cazzola S; Conidi A; Schellens A; van Dinther M; Stubbs A; Klippel A; Huylebroeck D; ten Dijke P; Verschueren K
Mol Cancer Res; 2009 Aug; 7(8):1342-53. PubMed ID: 19671686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]